Nymox Pharmaceutical
NYMX
#10186
Rank
A$27.41 M
Marketcap
Country
A$0.30
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -A$3.37 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -A$9.81 Million, an increase over its 2021 earnings that were of -A$18.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$3.37 Million-65.64%
2022 -A$9.81 Million-47.71%
2021 -A$18.75 Million6.61%
2020 -A$17.59 Million-10.91%
2019 -A$19.74 Million24.24%
2018 -A$15.89 Million-20.03%
2017 -A$19.87 Million2.71%
2016 -A$19.35 Million-63.86%
2015 -A$53.53 Million674.44%
2014 -A$6.92 Million-6.11%
2013 -A$7.37 Million-35.66%
2012 -A$11.45 Million-20.76%
2011 -A$14.44 Million38.33%
2010 -A$10.44 Million35.59%
2009 -A$7.7 Million11.8%
2008 -A$6.89 Million-12.94%
2007 -A$7.91 Million8.85%
2006 -A$7.27 Million36.5%
2005 -A$5.33 Million-4.4%
2004 -A$5.57 Million-14.58%
2003 -A$6.52 Million
2001 -A$4.79 Million-20.54%
2000 -A$6.02 Million21.72%
1999 -A$4.95 Million-25.56%
1998 -A$6.65 Million101.3%
1997 -A$3.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Abbott Laboratories
ABT
A$12.22 B-376,684.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.80 B-548,549.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$1.93 B-59,655.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.80 B-1,041,451.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.66 B-1,499,220.78%๐Ÿ‡บ๐Ÿ‡ธ USA